Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical data presented for adipoRon in cholangiocarcinoma

Feb. 1, 2018

Dermira begins phase IIb study of lebrikizumab in moderate to severe atopic dermatitis

Feb. 1, 2018

First patient treated in phase III study of BeiGene's tislelizumab

Feb. 1, 2018

Sumitomo Dainippon Pharma highlights progress of third quarter of fiscal 2017

Feb. 1, 2018

Armis Biopharma's Ximycin designated as QIDP by FDA

Feb. 1, 2018

Sanofi seeks EMA review of fexinidazole for sleeping sickness

Jan. 31, 2018

Inoperable HCC patients on tivozanib show durable tumor responses

Jan. 31, 2018

Phase III trial of sublingual apomorphine meets endpoints in patients with Parkinson's disease

Jan. 31, 2018

BridgeBio establishes QED Therapeutics to drive development of newly licensed infigratinib

Jan. 31, 2018

Kancera discovers ROR1 inhibitors

Jan. 31, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...